comparemela.com
Latest Breaking News On - Rapid abstract - Page 2 : comparemela.com
Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting
– Company Presents Poster on Overall Survival and Long-Term Safety Results from INTRIGUE Study; Second Poster Presents Analysis from INTRIGUE Patients without Detectable ctDNA at Baseline. | May 25, 2023
Germany
Australia
Israel
Hong-kong
Switzerland
Chicago
Illinois
United-states
Macau
United-kingdom
Canada
Taiwan
vimarsana © 2020. All Rights Reserved.